Shared upstream target, different downstream reach
Curcumin, ginger, garlic, Boswellia and omega-3 fatty acids are often grouped as natural anti-inflammatories because several converge on the transcription factor NF-kB, a master switch that turns on inflammatory genes. From there the routes diverge. Curcumin and ginger also touch the COX and LOX eicosanoid enzymes; Boswellia's boswellic acids are notable for inhibiting 5-lipoxygenase specifically; omega-3s work partly by being converted into less inflammatory signalling lipids and resolvins. Comparing them on one axis hides these mechanistic differences.
Reading the effect-size column honestly
Clinical effect sizes are generally modest and uneven across these agents, with the strongest controlled evidence in conditions like osteoarthritis for some (Boswellia, curcumin) and cardiovascular endpoints for omega-3s, while others rest mostly on mechanism. Bioavailability is a recurring limiter, especially for curcumin. None of these is a substitute for prescribed anti-inflammatory therapy in serious disease.
This is general educational information, not medical advice. Several of these interact with anticoagulants or other drugs, so dosing decisions should involve a qualified clinician.